Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

1DAY SOONER ACTION PROJECT INC.

Filed by 1DAY SOONER ACTION PROJECT INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-10-30 06:26:14 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 18, 2026
Income
Not reported
Expenses
$40,000.00
Filing UUID
d9e2e5e9-e982-4694-a9b7-6586a8a0caa4
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Clinical trial modernization legislation to make clinical trials faster, cheaper, and more efficient, including redlines on and support for Rep. Auchinclosss clinical trial bill, a supporting coalition letter, and introduction of a Senate companion (Sen. Hickenlooper); S. 4440, the Clinical Trial Modernization Act (Sen. Scott), including participant compensation provisions. Inclusion of pregnant individuals in clinical trials, including H.R. 8651, the Advancing Safe Medications for Moms and Babies Act of 2026 (Rep. Castor, Sen. Hickenlooper). FDA Sentinel system and real-world evidence provisions for potential health data legislation (Sen. Young), including an expert discussion with the office. Suggested questions to Senate staff for a hearing with Heidi Overton.

Literal federal measure citations: S. 4440, H.R. 8651

MED · Medical/Disease Research/Clinical Labs

S. 2333, Pandemic and All-Hazards Preparedness and Response Act (Hickenlooper - Budd Amendment to establish an emerging pathogen preparedness program through the FDA); FY25 & FY26 appropriations bills and NDAA (and report language) to ensure adequate resources for HHS and interagency / interdepartmental relationships for emerging pathogen and pandemic preparedness. Discussions with House and Senate offices about potential new legislation related to how the government encourages innovation in health care and other industries. Assistance with pursuing a letter of support from the Senate to the White House re: recent malaria vaccine developments; other interactions with the WH, HHS, and DoD to promote prompt distribution of malaria vaccines To support the FDA - DoD relationship to prioritize the development of safe and effective medical products that could save military personnel lives

Literal federal measure citations: S. 2333

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.